Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1437518
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1437518
Oncolytic Virotherapy Market, By Virus Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 301 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Oncolytic Virotherapy Market size was valued at USD 22.5 Million in 2023, expanding at a CAGR of 24.5% from 2024 to 2032.
The term "oncolytic virotherapy" refers to the process of eliminating cancerous cells within a tumor by viral replication. This phenomenon has a scientific foundation in viral tropism, which describes the selective preferences of certain viruses for specific cells. As a result, the ways that different viruses cause diseases vary. The majority of viruses found in nature are ideal for oncolysis because they exhibit a tropism for malignant cells. The measles virus, vaccinia virus, herpes simplex virus, reovirus, and other oncolytic viruses are examples of oncolytic viruses. Oncolytic viruses have been used in conjunction with radiation treatment and/or chemotherapy in certain experiments.
Oncolytic Virotherapy Market- Market Dynamics
Increasing collaboration to propel market demand
The increasing collaboration is expected to drive the oncolytic virotherapy industry during the forecast period. For instance, in July 2023, the clinical-stage immuno-oncology company Imugene Limited, with its headquarters in Sydney, Australia, and the clinical-stage biopharmaceutical company RenovoRx, Inc., based in Los Altos, California, developed targeted combination therapies, announced a strategic research collaboration to optimize the delivery of Imugene's oncolytic virus therapy with RenovoRx's transarterial microperfusion (TAMP) therapy platform for the treatment of tumors that are difficult to access. Imugene and RenovoRx will look into the possibility of using RenovoRx's TAMP treatment platform in conjunction with Imugene's CF33 oncolytic viral technology as part of their partnership.
Oncolytic Virotherapy Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 24.5% over the forecast period (2024-2032)
Based on virus type segmentation, the Genetically Engineered Oncolytic category dominates the market
Based on the application segmentation, the Solid Tumors segment held the largest market share in 2023
Based on end-use segmentation, the Hospitals segment is expected to dominate the market over the forecast period
Based on region, North America was the leading revenue generator in 2023
Oncolytic Virotherapy Market- Segmentation Analysis:
The Global Oncolytic Virotherapy Market is segmented based on Virus Type, Application, End-Use, and Region.
The market is divided into two categories based on virus type: Oncolytic Wild-Type Viruses and Genetically Engineered Oncolytic. The Genetically Engineered Oncolytic category dominates the market. Due to its ability to precisely transfer genes to targeted locations, therapies like adenovirus-based virotherapy are in greater demand, which has resulted in an increase in market share in this category.
The market is divided into two categories based on the application: Melanoma and Solid Tumors. The Solid Tumors segment held the largest market share in 2023 and is expected to continue the same pattern during the forecast period because of the increased prevalence of lung cancer, breast cancer, etc. Among women, breast cancer in particular continues to be a major cause of death.
The market is divided into three categories based on end-use: Cancer Research Institutes, Specialty Clinics and Hospitals. The Hospitals segment is expected to dominate the market over the forecast period because there are more and more hospitals offering cancer therapy. Government expenditures on medical infrastructure, combined with an increased patient focus on prompt and effective disease care, are other contributing factors to the segment's rise.
Oncolytic Virotherapy Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the market during the forecast period. One of the main reasons propelling the market is the growing cancer occurrences in the United States. According to a report by the American Cancer Society, 609,360 cancer deaths and around 1.9 million new cases of cancer were reported in the United States in 2022. In addition, several additional factors supported the market's growth in the area. These include the availability of cutting-edge immune-oncology medications, the expanding knowledge of the range of cancer therapy choices, and the rising cost of healthcare in nations like the United States.
Oncolytic Virotherapy Market- Competitive Landscape:
The key players operating in the market are CG Oncology Inc, Transgene SA, Amgen, Sorrento Therapeutics, Oncolys BioPharma, Targovax, Lokon Pharma, Vyriad, TILT Biotherapeutics, VCNBiosciences, DNAtrix, Replimune Group Inc. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.
Recent Developments:
In August 2022, Amgen invested a substantial USD 3.7 billion to purchase the biotech business ChemoCentryx. Amgen now has access to Tavneos, a critical medication that has already been approved for use in Europe and Japan, owing to this calculated approach. Amgen is well-positioned to fortify its position and increase its footprint in areas like Asia Pacific and Europe with this purchase.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ONCOLYTIC VIROTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
CG Oncology Inc
Transgene SA
Amgen
Sorrento Therapeutics
Oncolys BioPharma
Targovax
Lokon Pharma
Vyriad
TILT Biotherapeutics
VCNBiosciences
DNAtrix
Replimune Group Inc.
GLOBAL ONCOLYTIC VIROTHERAPY MARKET, BY VIRUS TYPE- MARKET ANALYSIS, 2019 - 2032
- Oncolytic Wild-Type Viruses
- Genetically Engineered Oncolytic
GLOBAL ONCOLYTIC VIROTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Melanoma
- Solid Tumors
GLOBAL ONCOLYTIC VIROTHERAPY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
- Cancer Research Institutes
- Specialty Clinics
- Hospitals
GLOBAL ONCOLYTIC VIROTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2236
Table of Contents
1. Oncolytic Virotherapy Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Oncolytic Virotherapy Market Snippet by Virus Type
- 2.1.2. Oncolytic Virotherapy Market Snippet by Application
- 2.1.3. Oncolytic Virotherapy Market Snippet by End-Use
- 2.1.4. Oncolytic Virotherapy Market Snippet by Country
- 2.1.5. Oncolytic Virotherapy Market Snippet by Region
- 2.2. Competitive Insights
3. Oncolytic Virotherapy Key Market Trends
- 3.1. Oncolytic Virotherapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Oncolytic Virotherapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Oncolytic Virotherapy Market Opportunities
- 3.4. Oncolytic Virotherapy Market Future Trends
4. Oncolytic Virotherapy Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Oncolytic Virotherapy Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Oncolytic Virotherapy Market Landscape
- 6.1. Oncolytic Virotherapy Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Oncolytic Virotherapy Market - By Virus Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Virus Type, 2023 & 2032 (%)
- 7.1.2. Oncolytic Wild-Type Viruses
- 7.1.3. Genetically Engineered Oncolytic
8. Oncolytic Virotherapy Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Melanoma
- 8.1.3. Solid Tumors
9. Oncolytic Virotherapy Market - By End-Use
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
- 9.1.2. Cancer Research Institutes
- 9.1.3. Specialty Clinics
- 9.1.4. Hospitals
10. Oncolytic Virotherapy Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Oncolytic Virotherapy Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Oncolytic Virotherapy Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Oncolytic Virotherapy Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Oncolytic Virotherapy Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Oncolytic Virotherapy Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Virus Type, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Oncolytic Virotherapy Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. CG Oncology Inc
- 11.2.2. Transgene SA
- 11.2.3. Amgen
- 11.2.4. Sorrento Therapeutics
- 11.2.5. Oncolys BioPharma
- 11.2.6. Targovax
- 11.2.7. Lokon Pharma
- 11.2.8. Vyriad
- 11.2.9. TILT Biotherapeutics
- 11.2.10. VCNBiosciences
- 11.2.11. DNAtrix
- 11.2.12. Replimune Group Inc.
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV2236
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Oncolytic Virotherapy Market: Virus Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Virus Type
- TABLE Global Oncolytic Virotherapy Market, by Virus Type 2019-2032 (USD Million)
- TABLE Oncolytic Virotherapy Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Oncolytic Virotherapy Market, by Application 2019-2032 (USD Million)
- TABLE Oncolytic Virotherapy Market: End-UseSnapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End-Use
- TABLE Global Oncolytic Virotherapy Market, by End-Use2019-2032 (USD Million)
- TABLE Oncolytic Virotherapy Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Oncolytic Virotherapy Market, by Region 2019-2032 (USD Million)
- TABLE North America Oncolytic Virotherapy Market, by Country, 2019-2032 (USD Million)
- TABLE North America Oncolytic Virotherapy Market, by Virus Type, 2019-2032 (USD Million)
- TABLE North America Oncolytic Virotherapy Market, by Application, 2019-2032 (USD Million)
- TABLE North America Oncolytic Virotherapy Market, by End-Use, 2019-2032 (USD Million)
- TABLE Europe Oncolytic Virotherapy Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Oncolytic Virotherapy Market, by Virus Type, 2019-2032 (USD Million)
- TABLE Europe Oncolytic Virotherapy Market, by Application, 2019-2032 (USD Million)
- TABLE Europe Oncolytic Virotherapy Market, by End-Use, 2019-2032 (USD Million)
- TABLE Asia Pacific Oncolytic Virotherapy Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Oncolytic Virotherapy Market, by Virus Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Oncolytic Virotherapy Market, by Application, 2019-2032 (USD Million)
- TABLE Asia Pacific Oncolytic Virotherapy Market, by End-Use, 2019-2032 (USD Million)
- TABLE Latin America Oncolytic Virotherapy Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Oncolytic Virotherapy Market, by Virus Type, 2019-2032 (USD Million)
- TABLE Latin America Oncolytic Virotherapy Market, by Application, 2019-2032 (USD Million)
- TABLE Latin America Oncolytic Virotherapy Market, by End-Use, 2019-2032 (USD Million)
- TABLE Middle East and Africa Oncolytic Virotherapy Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Oncolytic Virotherapy Market, by Virus Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Oncolytic Virotherapy Market, by Application, 2019-2032 (USD Million)
- TABLE Middle East and Africa Oncolytic Virotherapy Market, by End-Use, 2019-2032 (USD Million)
List of Figures
- FIGURE Oncolytic Virotherapy Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Virus Type segment market share analysis, 2023 & 2032
- FIGURE Virus Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Application segment market share analysis, 2023 & 2032
- FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE End-Usesegment market share analysis, 2023 & 2032
- FIGURE End-Usesegment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America Oncolytic Virotherapy Market share and leading players, 2023
- FIGURE Europe Oncolytic Virotherapy Market share and leading players, 2023
- FIGURE Asia Pacific Oncolytic Virotherapy Market share and leading players, 2023
- FIGURE Latin America Oncolytic Virotherapy Market share and leading players, 2023
- FIGURE Middle East and Africa Oncolytic Virotherapy Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe Oncolytic Virotherapy Market share analysis by country, 2023
- FIGURE Germany Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Oncolytic Virotherapy Market share analysis by country, 2023
- FIGURE India Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Phillipines Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Oncolytic Virotherapy Market share analysis by country, 2023
- FIGURE Brazil Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Oncolytic Virotherapy Market share analysis by country, 2023
- FIGURE Saudi Arabia Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA Oncolytic Virotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.